Terug
Dagbereik
€ 0,95
€ 1,00
52-Weeksbereik
€ 0,93
€ 1,43
Volume
5.000
50D / 200D Gem.
€ 1,01
/
€ 1,06
Vorige Slotkoers
€ 1,00
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 10,9 | 0,4 |
| P/B | 1,6 | 2,9 |
| ROE % | 1,5 | 3,8 |
| Net Margin % | 9,2 | 3,9 |
| Rev Growth 5Y % | 6,6 | 10,0 |
| D/E | 0,7 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 3,56
€ 3,49 – € 3,61
|
25 B | 1 |
| FY2028 |
€ 2,63
€ 2,58 – € 2,67
|
21 B | 1 |
| FY2027 |
€ 2,44
€ 2,39 – € 2,48
|
20 B | 1 |
Belangrijkste Punten
Revenue grew 6,58% annually over 5 years — modest growth
Earnings declined -94,03% over the past year
ROE of 1,46% is below average
Generating 46,55M in free cash flow
P/E of 10,92 — trading at a low valuation
Capital efficient — spends only 3,12% of revenue on capex
Groei
Revenue Growth (5Y)
6,58%
Revenue (1Y)9,03%
Earnings (1Y)-94,03%
FCF Growth (3Y)-20,92%
Kwaliteit
Return on Equity
1,46%
ROIC14,91%
Net Margin9,16%
Op. Margin21,26%
Veiligheid
Debt / Equity
0,69
Current Ratio1,77
Interest Coverage3,56
Waardering
P/E Ratio
10,92
P/B Ratio1,58
EV/EBITDA5,99
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9,03% | Revenue Growth (3Y) | 0,18% |
| Earnings Growth (1Y) | -94,03% | Earnings Growth (3Y) | 18,13% |
| Revenue Growth (5Y) | 6,58% | Earnings Growth (5Y) | 8,78% |
| Profitability | |||
| Revenue (TTM) | 973,01M | Net Income (TTM) | 89,16M |
| ROE | 1,46% | ROA | 6,74% |
| Gross Margin | 62,84% | Operating Margin | 21,26% |
| Net Margin | 9,16% | Free Cash Flow (TTM) | 46,55M |
| ROIC | 14,91% | FCF Growth (3Y) | -20,92% |
| Safety | |||
| Debt / Equity | 0,69 | Current Ratio | 1,77 |
| Interest Coverage | 3,56 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | 10,92 | P/B Ratio | 1,58 |
| P/S Ratio | 1,00 | PEG Ratio | -0,12 |
| EV/EBITDA | 5,99 | Dividend Yield | 0,04% |
| Market Cap | 973,79M | Enterprise Value | 1,24B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 973,01M | 892,41M | 969,48M | 862,36M | 754,10M |
| Net Income | 89,16M | 1,49B | 63,89M | 71,22M | 63,68M |
| EPS (Diluted) | 0,09 | 1,53 | 0,07 | 0,07 | 0,06 |
| Gross Profit | 611,40M | 572,23M | 593,52M | 521,09M | 465,65M |
| Operating Income | 206,90M | 188,13M | 188,96M | 169,35M | 145,92M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,32B | 1,10B | 1,22B | 1,11B | 1,05B |
| Total Liabilities | 705,75M | 581,91M | 664,14M | 587,25M | 558,53M |
| Shareholders' Equity | 616,35M | 11,59B | 552,42M | 520,52M | 490,44M |
| Total Debt | 424,54M | 311,15M | 6,24B | 330,24M | 290,25M |
| Cash & Equivalents | 158,62M | 2,38B | 1,47B | 77,10M | 61,59M |
| Current Assets | 712,15M | 12,07B | 10,67B | 579,98M | 560,98M |
| Current Liabilities | 401,22M | 6,54B | 6,62B | 479,70M | 319,96M |